Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Leukemia L 1210

morpholinoanthracycline mx2 has been researched along with Leukemia L 1210 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Komeshima, N; Nakajima, S; Tsuruo, T; Watanabe, M	1

Other Studies

1 other study(ies) available for morpholinoanthracycline mx2 and Leukemia L 1210

Article	Year
MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells. Cancer research, 1988, Dec-01, Volume: 48, Issue:23 Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Doxorubicin; Drug Resistance; Humans; Leukemia L1210; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous; Tumor Cells, Cultured	1988

Article

Year

MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.

Cancer research, 1988, Dec-01, Volume: 48, Issue:23

Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Doxorubicin; Drug Resistance; Humans; Leukemia L1210; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous; Tumor Cells, Cultured

1988